A clinical trial, led by Dr. Mas Takashima, is providing strong long-term evidence that a minimally invasive, office-based procedure can deliver sustained relief for patients with chronic rhinitis.

We sat down with our assistant professor of neurology Dr. Jon Toledo to shed light on why Lewy pathology must be a crucial consideration when designing clinical trials for neurodegenerative diseases.

A multicenter randomized controlled trial, co-authored by Drs. Omar Ahmed and Mas Takashima, has demonstrated that impedance-controlled multipoint radiofrequency ablation significantly improves symptoms and quality of life for patients with chronic rhinitis.

Join us for the 10th Annual #Cardiology for the Non-Cardiologist Conference. This event will teach non-cardiovascular health care providers to identify common risk factors and understand guidelines for #cardiovascular diseases. Register: spr.ly/63325B6orvl

Flu season has become more than a clinical challenge — it’s a real-world stress test for the health system’s artificial intelligence ecosystem. See how our organization’s digital infrastructure supports clinicians under pressure.

We spoke with Dr. Omar Ahmed about his work to better understand the unresolved questions in chronic rhinosinusitis research and treatment, and how these insights could ultimately inform clinical care.

Most patients with hepatocellular carcinoma fail to respond to current immune checkpoint inhibitors. New research, led by Dr. Dan Duda, suggests tumor-associated B cells may be a key driver of resistance and a promising therapeutic target.

A new 3D-printed vacuum coupler, designed by Dr. Carly S. Filgueira, reduced cardiac motion during ultrasound-mediated imaging in an open-chest heart model, according to our study that shows promise for reducing inaccuracies and improving patient outcomes.

We’ve announced a collaboration with Texas Children's to establish the Fondren IBD Transition Program, an initiative designed to support children & young adults living with inflammatory bowel disease as they make the transition from pediatric to adult care.

Join us for the 10th Annual #Cardiology for the Non-Cardiologist Conference. This event will teach non-cardiovascular health care providers to identify common risk factors and understand guidelines for #cardiovascular diseases. Register: spr.ly/63325B6orSc

ICU survival is just the beginning. Our Critical Care Recovery Clinic integrates intensivists, therapists, pharmacists & psychologists to close gaps in post-ICU care and improve long-term outcomes. Advancing survivorship care step by step.

Our critical care specialist Dr. Hina Faisal has received a NIH career development award to investigate whether immersive virtual reality therapy can help prevent ICU delirium.

Alzheimer’s and Lewy pathology frequently co-occur and significantly impact clinical presentation & cognitive decline. Understanding these overlaps is essential for accurate diagnosis, biomarkers & combination therapies.

A new algorithm provides a more accurate method for estimating left ventricular filling pressure (LVFP) by echocardiography, according to a validation study led by Medical Director of our Echocardiography Laboratory Dr. Sherif Nagueh.

The coexistence of Lewy body dementia and Alzheimer’s leads to significantly faster rates of cognitive decline compared to either pathology alone, according to our study that begins unraveling the interplay between the two diseases.

Patients on long-term steroids face nearly three times the risk of developing life-threatening blood clots after complex spine surgery, according to a study led by our orthopedic spine surgeon Dr. Comron Saifi.

Our thoracic surgery division, under Dr. Min Kim's leadership, has set new benchmarks for outcomes and innovation thanks to a data-driven culture, robotic adoption & enhanced recovery pathways.

Dr. Sudha Kodali reviews Transplant Oncology: A Frontier in Multidisciplinary Cancer Care, edited by Dr. Maen Abdelrahim—an important resource for clinicians advancing cancer care through transplantation.

Our research team, led by Dr. Rose Khavari, has demonstrated for the first time that functional MRI can be used to capture real-time activity in the human spinal cord regions responsible for bladder control.

Patients with a particularly aggressive form of metastatic colorectal cancer may benefit from a novel combination of targeted therapy and immunotherapy, according to a Houston-led phase 1/2 clinical trial.

We recruited internationally recognized cardiologist @drmarthagulati.bsky.social to lead our new Davis Women’s Heart Center, marking a major investment in the prevention, diagnosis and treatment of heart disease in women.

Three interconnected areas of research, led by Drs. Dimitry Sayenko, Amir Faraji and Sean Barber, are combining peripheral transfers, bioelectronics, transcutaneous spinal cord stimulation and other technologies to advance SCI treatments.

We've received FDA approval for Gallium Ga 68 Edotreotide Injection, an advanced imaging agent that helps physicians more precisely detect certain neuroendocrine tumors. This milestone makes us the 2nd center in the nation to receive approval for a diagnostic agent of this kind.

In contrast to pediatric-based models, our ACHD Program operates entirely in an adult heart hospital setting — improving continuity for adult complications without fragmented handoffs.

One of the great barriers to outstanding U.S. health care is limited English proficiency. Learn more about how our innovative technology is breaking down those walls.

Two new studies led by our hepatologist Dr. Mazen Noureddin provide the strongest evidence to date that cirrhosis caused by metabolic dysfunction-associated steatohepatitis (MASH) may be reversible — a milestone once considered unattainable in hepatology.

Assistant Professor of Neurosurgery Dr. Amir Faraji is developing new techniques and methodologies to improve patient outcomes for neurodegenerative diseases.

Physician-researchers Dr. Stanley Appel and Aaron Thome have made significant progress unraveling the mechanics of amyotrophic lateral sclerosis (ALS) and Parkinson’s and Alzheimer’s diseases.

An artificial intelligence-driven wearable device may offer a meaningful, noninvasive treatment option for people with essential tremor, according to a study led by our Professor of Neurology Dr. William Ondo.

Recent advances in spinal stimulation research are reshaping how clinicians and scientists understand recovery potential after spinal cord injury, thanks in part to a series of studies led by our Associate Professor in Neurosurgery Dr. Dimitry Sayenko.

A new multicenter study, led by our researchers and Rice University researchers, has identified four distinct patient profiles in aortic regurgitation.

Learn more about how we're using artificial intelligence-enabled virtual care platforms and embedded sensors to make our hospital rooms self-aware care spaces.

A new interdisciplinary project led by Rice University and our Research Institute aims to clarify how the brain adapts to neural implants over time.

Our new study offers a clearer picture of how Alzheimer's disease may influence the body far beyond the brain — specifically by interfering with the way nerves and blood vessels communicate inside fat tissue.

Orbital decompression surgery has declined significantly since the Food and Drug Administration's 2020 approval of the biologic teprotumumab, according to a national analysis led by Drs. Omar Ahmed and Amina Malik.

In a recent published review, Chief of Gastroenterology Dr. Eamonn Quigley is calling for a fundamental reset in how scientific and medical communities — and the public — think about probiotics, the increasingly trendy intervention for some gut problems.

In a comprehensive recent review article, our Chief of Gastroenterology Dr. Eamonn Quigley examines how the gut microbiome and its metabolic products contribute to irritable bowel syndrome — and where misconceptions continue to cloud the field.

New findings from our team, led by Drs. Hongbo Gao and Keith Syson Chan, suggest that chemo-induced cell death might also release signals that promote drug resistance.

The diagnosis of small intestinal bacterial overgrowth (SIBO) has undergone a major conceptual drift — and not necessarily for the better, according to a recent review by our Chief of Gastroenterology Dr. @eamonnquigleymd. spr.ly/633237ngkb

More than a century after Pavlov's dog established the role of external cues in associative learning, our researchers have discovered that the brain can internalize and replay rhythms of stimulation even without reward, meaning or a conditioned signal.

We're working to take patient surveying to the next level by developing future technology that will yield even more useful predictive analytic models.

A new review, led by Chair of Obstetrics and Gynecology Dr. Pedro Ramirez, recommends a shift from one-size-fits-all surgical practices to a more risk-adapted, patient-specific approach to treating early-stage cervical cancer.

The Houston Methodist–Rice Digital Health Institute have formally launched, underscoring the institutions' shared vision to serve as a translational engine for an industry where data, artificial intelligence, engineering and medicine converge.

Our researchers, led by Dr. Muralidhar L. Hegde, have uncovered a novel role for the RNA/DNA-binding protein TDP43, showing that it directly regulates DNA mismatch repair genes — a finding that could reshape understanding of both neurodegenerative disease and cancer.

Researchers at our Academic Institute, led by Dr. Stefano Casarin, have unveiled a groundbreaking computational model that could transform how scientists study and treat bone metastasis, one of the deadliest complications of advanced cancers.

Dubbed the hospital of the future, our Cypress Hospital represents an investment in improving patient care, hospital efficiency and the day-to-day workloads of doctors and nurses.

Our Chief of Cardiovascular Disease Prevention and Wellness Dr. Khurram Nasir recently appeared on @houstonpublicmedia.bsky.social's "Hello Houston" to discuss the Houston Methodist-Rice University Digital Health Institute and their work to shape the future of digital health.

In this episode of Quality Time with Dr. Shlomit Schaal, nursing leaders Gail M. Vozzella and Caroline Mascarenhas discuss how virtual nursing and innovative technology have improved patient safety and more.

After successfully bringing ambient listening into our outpatient settings, we’re now piloting the use of the clinical voice technology in new territory: the emergency department and in-patient care.

Our first-of-its-kind study found that adipose-derived extracellular vesicles can signal the buildup of amyloid-β plaque—a key feature of Alzheimer’s disease—in obese individuals.